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Abstract
Background: With the accumulation of evidence regarding potential harms of cancer screening in recent years,
researchers, policy-makers, and the public are becoming more critical of population-based cancer screening.
Consequently, a high-quality cancer screening program should consider individuals’ values and preferences when
determining recommendations. In cervical cancer screening, offering women autonomy is considered a “person-
centered” approach to health care services; however, it may impact the effectiveness of the program should women
choose to not participate. As part of a larger project to investigate women’s cervical screening preferences and
correlates of these preferences, this systematic review will capture quantitative and qualitative investigations of
women’s cervical screening preferences and the methods used to elicit them.
Design and methods: This mixed methods synthesis will use a thematic analysis approach to synthesize qualitative,
quantitative, and mixed methods evidence. This protocol describes the methods that will be used in this investigation.
A search strategy has been developed with a health librarian and peer reviewed using PRESS. Based on this strategy,
five databases and the gray literature will be searched for studies that meet the inclusion criteria. The quality of the
included individual studies will be examined using the Mixed Methods Appraisal Tool. Three reviewers will extract data
from the primary studies on the tools or instruments used to elicit women’s preferences regarding cervical cancer
screening, theoretical frameworks used, outcomes measured, the outstanding themes from quantitative and qualitative
evidence, and the identified preferences for cervical cancer screening. We will describe the relationships between study
results and the study population, “intervention” (e.g., tool or instrument), and context. We will follow the PRISMA
reporting guideline. We will compare findings across studies and between study methods (e.g., qualitative versus
quantitative study designs). The strength of the synthesized findings will be assessed using the validated GRADE and
CERQual tool.
Discussion: This review will inform the development of a tool to elicit women’s cervical screening preferences.
Understanding the methods used to elicit women’s preferences and what is known about women’s cervical screening
preferences will be useful for guideline developers who wish to incorporate a woman-centered approach specifically
for cervical screening guidelines.
Systematic review registration: PROSPERO CRD42016035737
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Background
Health care providers and public health organizations
have enthusiastically promoted the importance of cancer
screening for several years as some cancer screening pro-
grams have been found to reduce mortality from the dis-
ease [1, 2]. However, debates about the risks and benefits
of cancer screening are occurring in the academic and the
public domains [3–5]. For example, several organizations
do not recommend population-based prostate-specific
antigen testing because the harms outweigh the benefits
[6–8], and recent publications question the optimal age
range for mammography screening [9, 10]. In some juris-
dictions, people are offered choices about what method of
colorectal cancer screening they would prefer, though ac-
cess to these options may be variable [11–14]. While most
health professionals agree that personalized cancer screen-
ing would benefit their patients, the decision-making
process is usually left to clinicians. Often, patients are not
presented with a decision between screening options for
pragmatic reasons: health systems are organized to evaluate
and reimburse clinicians based on specific guideline adher-
ence (which may not include a personalized pathway), cli-
nicians may disagree with personalized recommendations,
or certain options may require extra resources [15]. Add-
itionally, health professionals have expressed concern that
options may deter individuals from pursuing cancer
screening, which could affect cancer rates among the
population, although there appears to be no evidence to
substantiate this [13, 15, 16] The benefits of early cancer
detection and potential treatment must be weighed against
harms such as complications from the screening process
(e.g., perforation from colonoscopy), potential for false pos-
itives and false negatives, anxiety resulting from receiving
abnormal results, and treatment of conditions that may not
have developed into a problem, which can vary widely
based on a patient’s age and health status [15].
Cervical cancer screening has avoided some of the media
controversy that has affected breast, prostate, and recently
colorectal screening programs because the Papanicolaou
(Pap) test has successfully reduced the incidence of invasive
cervical cancer and associated mortality [17–19]. In On-
tario, Canada, the provincial cancer agency now recom-
mends a new method of screening—human papillomavirus
(HPV) testing—because of its increased sensitivity for de-
tecting cervical abnormalities and high negative predictive
value for high-grade cervical intra-epithelial neoplasia,
compared with Pap testing [20]. Such a change in screening
test would require cervical screening stakeholders to make
decisions about the age range during which screening
should be offered, options for sample collection methods,
options for the laboratory testing, screening frequency, and
recommended follow-up algorithm. In particular, HPV test-
ing has the option for self-collection, which would allow
women to take their own samples without the supervision
of a health care professional, though possibly at a cost of
slightly decreased diagnostic performance [21, 22]. This
strategy could have implications for access to screening,
screening frequency, follow-up algorithms, and how screen-
ing results are communicated to women. As for most other
health care decisions, women and health care professionals
would be expected to make cervical screening choices that
maximize the potential for early detection of a disease and
minimize harm [23]. Population-level benefits and harms
are balanced on a broader scale, looking at reduced disease-
specific morbidity and mortality compared to overly inten-
sive screening strategies [24]. Cancer screening decisions
such as this one are inherently preference sensitive at both
the individual level and program level, as decision-makers
are required to understand how they value the benefits and
harms for the different elements of the decision [25–27].
Therefore, individuals can identify their preferred choice by
considering how they value each option’s benefits and risks.
According to the Ottawa Decision Support Framework
(ODSF), preference refers to the most appealing option of a
decision for an individual, which is identified through
values clarification [28, 29]. Values clarification is a process
in which individuals identify the characteristics that matter
most to them for a specific health decision. In cancer
screening, individuals would compare and contrast what
the tests measure, their diagnostic performance, how the
tests are performed, follow-up procedures, and the poten-
tial consequences of participating in screening, and, subse-
quently, identify a plan to act on these preferences [30]. In
the ODSF, values clarification and preference elicitation are
part of shared decision-making processes, in which individ-
uals are supported in these exercises by a decision support
person [29]. Llewellyn-Thomas and Crump identified inter-
active and non-interactive, fine-grained, and coarse-grained
approaches to values clarification and preference elicitation
for health care decision-making in their 2013 review [29].
As the authors note, there are conceptual and meth-
odological issues between the different values clarifica-
tion/preference eliciting approaches, and further research
is required to determine the appropriate approach based on
different subgroups of patients. Considering the evolving
and complex evidence in cervical cancer screening, it is im-
perative that women are supported in these preference-
sensitive health care decisions, for individual-level decision-
making and through policies that reflect women’s
preferences.
Systematic reviews have shown that more women may
participate in cervical screening if they can self-collect their
samples [31, 32]. Other reviews have indicated that women
tend to prefer active follow-up of abnormal screening re-
sults, predominantly referral to colposcopy, to observation,
and predominantly repeated Pap tests [33]. In studies in-
vestigating women’s views on HPV testing as part of cer-
vical cancer screening [34], some respondents had trouble
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interpreting information about cervical cancer screening
[33]. This was related to psychosocial burden of positive re-
sults, acceptability of the testing process, and women’s in-
formational needs [34]. There is weak evidence that
women’s participation in cancer screening is related to the
presentation of the screening information as well as emo-
tional and cognitive responses to the invitation to be
screened [35]. While there is a growing body of evidence
focusing on women’s attitudes and beliefs in cervical
screening, it is unclear whether these studies consider
women’s preferences in terms of making informed deci-
sions, which undermines the potential for improved
screening for women. To the best of our knowledge, no
systematic review has described or compared methods
for eliciting women’s cervical screening preferences and
the outcomes of these approaches. The proposed re-
view will contribute to an assessment of women’s needs
in making decisions about primary cervical cancer screen-
ing and inform policy-makers and guideline developers
about these needs. These findings will be used in an inves-
tigation of women’s cervical screening preferences in
Ontario, Canada.
Aim
The objectives of this systematic review are
(1)to synthesize and describe what is known about
methods used to elicit women’s preferences in
primary cervical cancer screening;
(2)to summarize the evidence on women’s preferences
for cervical cancer screening.
Methods
This protocol has been prepared following Preferred
Reporting Items for Systematic Review and Meta-Analysis
Protocols (PRISMA-P) guidelines for systematic review
protocols [36]. The PRISMA-P checklist is included as
Additional file 1. The review protocol has been registered
with PROSPERO (CRD42016035737).
Conceptual framework
This systematic review is part of an assessment of
women’s needs in identifying their preferences and mak-
ing decisions about cervical cancer screening, taking into
account issues laid out in the ODSF [28, 37]. We will
apply this framework to conduct a thematic analysis of
the synthesis results, looking at determinants of prefer-
ences and decision-making, methods used to support
decision-making or elicit preferences, and short- and
long-term outcomes [28, 29, 37]. In addition to summar-
izing different techniques of eliciting preferences, we will
compare theoretical frameworks used to elicit preferences,
processes used to design these techniques, outcomes in-
cluding construct validity, clinical outcomes, and decision
quality, the identified preferences for cervical cancer
screening, and how these preferences are influenced
by context.
Eligibility
We will evaluate qualitative and quantitative studies that
describe and/or examine methods used to elicit women’s
cervical screening preferences. These studies will involve
women being presented with multiple options for pri-
mary cervical cancer screening and identifying the most
favored option [29]. We will include studies of women
who are presented with options at the point of decision-
making, as well as women presented with a hypothetical
decision. The criteria for inclusion in this review are
summarized in Table 1. For all study designs, we will
examine studies in which women are 18 years of age or
older and are eligible for cervical cancer screening. We
will include articles that are based on direct enquiry with
eligible women with no restriction on publication dates
or publication status. For articles not published in Eng-
lish that the study team is unable to translate, we will at-
tempt to contact the study authors to see if there are
any English translations available. All study designs will
be included. Mixed methods studies that satisfy corre-
sponding inclusion and exclusion criteria will also be in-
cluded (eligibility will be determined separately for the
quantitative and qualitative components). We will exam-
ine each of the primary studies from any systematic re-
view or meta-analysis for individual inclusion into the
review. Opinion pieces will not be included.
Information sources
We will search MEDLINE, Embase, PsycINFO, CINAHL,
and Cochrane Library databases, for English articles from
Table 1 Eligibility criteria for studies in systematic review
Inclusion criteria Exclusion criteria
- Participants: women aged
≥18 years
- Assessment of women’s
cervical screening preferences,
either current or hypothetical
- Investigation of decision-
making needs of women
who are considering cervical
cancer screening
- Both qualitative and
quantitative study designs
- Interventions targeting health
care providers, policy-makers
(e.g., program decision-makers),
or technical aspects of cervical
cancer screening or treatment
- Reports of interventions that
aim to increase cervical screening
uptake in which the content of
the intervention was not described
or evaluated
- Studies reporting predictors of
cervical screening uptake that
are not related to a decision-
making process
- Opinion pieces
- Studies that do not adequately
report the study design, methods,
and interpretation of the research
- Studies that do not clearly
demonstrate ethical conduct
or ethical reporting of research
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inception to March 2016. The gray literature will be
searched by scanning ProQuest Dissertations and
Theses, relevant Canadian health research/policy data-
bases, Canadian health information networks, and known
relevant Canadian conference proceedings. Our gray lit-
erature search is limited to Canadian resources as the
findings from this review will inform an investigation of
cervical screening preferences in the Canadian context. A
search strategy and its translations to other databases were
developed in collaboration with a health sciences librarian
at the University of Ottawa and peer reviewed using
PRESS [38]. These strategies combined free-text words
and subject headings, derived from the following broad
topic areas: cervical cancer, early detection of cervical can-
cer, and patient preferences. The MEDLINE search strat-
egy is appended (Additional file 2). We will search
citations of the included studies using SCOPUS to supple-
ment our search of the main bibliographic databases. Ref-
erence lists of articles that were selected for full-text
review will be scanned for additional relevant material.
Subject matter specialists on the review team will be asked
to identify further resources for inclusion.
Study identification and data extraction
Two of three reviewers will independently review the
studies in three stages: (i) title and abstract screening for
inclusion; (ii) full-text screening for inclusion; and (iii)
data extraction for eligible studies. All studies which ini-
tially appear to meet the inclusion criteria but on inspec-
tion of the full-text paper are not eligible will be detailed
in a table. We will identify single studies that are re-
ported in multiple publications by juxtaposing the au-
thor lists and comparing sample size and setting
characteristics. Multiple reports of the same study will
be considered for inclusion, but the data will be ex-
tracted for single studies from the report deemed the
most relevant by the two reviewers. Variation in results
reported in multiple publications will be noted as limita-
tions in the appraisal of each study. Characteristics of
excluded studies’ together with reasons for their exclu-
sion will be recorded. Disagreements regarding eligibility
of studies will be resolved by the third reviewer.
Data will be extracted independently by two of the three
reviewers, according to the list in Table 2. Mendeley
(www.mendeley.com) and Covidence (www.covidence.org)
will be used for citation management, screening, and data
extraction. Data will be extracted to preserve the context of
the findings, as described by Sandelowski et al. [39] using
pre-defined data extraction forms. Descriptive themes of
preference eliciting methods and preferred cervical screen-
ing options will be developed for each primary study based
on the text-in-context results [39]. Differences will be re-
solved through discussion between the two reviewers, and
if necessary, through final consensus with a third reviewer.
Customized data extraction sheets will be pilot tested by all
reviewers prior to the data extraction phase.
Outcomes
Objective 1: The first objective is to synthesize what is
known about methods used to elicit women’s prefer-
ences in primary cervical cancer screening, including
– Approaches used to elicit women’s preferences for
screening technologies (e.g., interactive versus non-
interactive, coarse-grained versus fine-grained,
other);
– Methods used to evaluate the appropriateness of
women’s preferences (e.g., strength of preferred
option, change in decisional conflict, acceptability of
option’s characteristics, change in knowledge,
attitudes, or behavior);
– Reported indicators of effectiveness of methods to
elicit preferences (e.g., observed strengths of
preferences, observed changes in decisional conflict,
observed acceptability of options, observed changes in
knowledge, attitudes, or behavior);
– Advantages and disadvantages of the different
methods to elicit preferences.
Table 2 Data extraction fields for synthesis
Study details Eligibility Study design Clinical/decision-making issues Summary
Author, year
Reference ID






















Method of data collection










Results (preferred option, strength
of preferred option, evaluation
of preference eliciting technique)
Total number of participants
Objective 1: magnitude and
significance; study-specific conceptions
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Objective 2: The second objective is to summarize the
evidence on women’s preferences for cervical cancer
screening, including
– List of options in cervical screening decisions for
women;
– Women’s preferences for cervical screening (by
proportions), by jurisdiction;
– Description of important values for making cervical
screening decisions.
Quality assessment/risk of bias
The Mixed Methods Appraisal Tool (MMAT) [40, 41]
will be used to appraise the qualitative, quantitative, and
mixed methods studies for this review. Two reviewers
will independently appraise relevant studies, and dis-
agreement will be resolved through consensus, in discus-
sion with a third reviewer. Studies will be included in
the final review if they score 50 % or greater, according
to the scoring scheme [40].
The Grading of Recommendations, Assessment, Devel-
opment and Evaluation (GRADE) guidelines will be used
to present a summary of findings and to qualify the
strength of individual findings for the quantitative and
qualitative syntheses separately, using GRADE profiler
and the Confidence in the Evidence from Reviews of
Qualitative Evidence (CERQual) tool, respectively [42–45].
Analysis
The quantitative and qualitative evidence will be analyzed
separately and then combined in the final stage of analysis,
similar to Goldsmith’s integrated methodology [46]. We
expect considerable heterogeneity between studies and
therefore that a statistical meta-analysis would not be ap-
propriate. A tabular summary will be created to describe
all of the characteristics of the included studies, as well as
key preference eliciting methodologies [47], the advan-
tages and disadvantages of their approaches, and their
conclusions regarding women’s preferences based on the
text-in-context analysis.
Objective 1: We will produce a quantitative evidence
table that describes the main types of preference eliciting
methods identified in the quantitative body of literature
and may also contain relevant evaluative measurements
of the different techniques. Methods will be categorized
using themes from a textual analysis technique when
reviewing the qualitative literature, using the classifica-
tion as outlined by Llewellyn-Thomas and Crump [29]
as an initial reference. A similar evidence summary table
of the included qualitative studies will be developed,
conveying study characteristics, context, and outstanding
themes. In both of these summary thematic tables, we
will also include a column that indicates if and how the
themes map onto the ODSF concepts.
Objective 2: Women’s preferences will be organized into
themes using the text-in-context analysis and presented in
a table, alongside the options available and values that
women identified as important for their decision-making.
Quantitative evidence will be synthesized and presented
separately from the qualitative evidence.
For both objectives, summary of findings tables will be
developed according to the GRADE guidelines (i.e.,
GRADE and CERQual) for syntheses of the quantitative
and qualitative evidence separately. Evidence profiles
[46] will be created for each finding to determine recom-
mendations for eliciting women’s cervical screening prefer-
ences, for each objective. These profiles will be presented
in a table that denotes which studies contribute evidence
toward a particular theme, the associated type of evidence
(i.e., qualitative or quantitative), related quality appraisal
scores from the MMAT, the consistency of the finding
across the studies (e.g., noting any contradictions or miss-
ingness), the applicability of the evidence to the Ontario/
Canadian population, and any other factors that might in-
fluence the usability of the evidence. Each evidence profile
will include overall assessments from the GRADE and
CERQual summary of findings tables. Using the categories
defined by Goldsmith et al. [46], analytic themes will be
graded as “definite” or “suggestive,” based on the GRADE
and CERQual assessments. Items which were classified as
“high” or “moderate” according to GRADE or CERQual
will be given a “definite” recommendation, and items clas-
sified as “low” and/or “very low” will be denoted “suggest-
ive.” This method of synthesis will clarify the important
dimensions of eliciting women’s preferences for cervical
screening, giving equal value to quantitative and qualitative
evidence. “Definite” recommendations from the evidence
profile will be used to develop a tool to elicit women’s
screening preferences in practice. “Suggestive” recommen-
dations will be discussed with local stakeholders to deter-
mine their relevance for this particular project and can be
used to guide further research on women’s screening
preferences.
Discussion
This study will be the first systematic review synthesizing
methods used to elicit preferences for cervical cancer
screening. This review constitutes the first part of a needs
assessment for the development of a tool to elicit women’s
preferences for different cervical cancer screening options.
The findings of this review will inform a qualitative inves-
tigation of women’s cervical screening decision-making in
Canada.
Strengths and limitations
Recommendations for mixed methods systematic reviews
were developed only recently [46, 48–50], and therefore,
best practices have not yet been fully established. While
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this study will use some validated approaches to synthesiz-
ing quantitative and qualitative evidence, it may be chal-
lenging to apply the results of this synthesis because of the
heterogeneity of the evidence. This mixed methods ap-
proach values quantitative and qualitative evidence equally,
offering a more complex understanding of how women
make decisions about cervical cancer screening.
As with any knowledge synthesis, this review will be
subject to particular biases, including publication bias
and language bias. This review will be examining the
gray literature to attempt to find relevant unpublished
work. If there are relevant articles identified that are not
published in English, the authors will seek to translate
the document internally or will attempt to retrieve a
translation by contacting the author. We expect that the
heterogeneity in definitions of “preference” and potential
reporting biases may complicate the synthesis of across
a diverse body of literature. This review will contribute
to improved understanding of how best to elicit cancer
screening preferences from women, which women,
health care providers, and policy-makers may value. A
thematic synthesis may not provide the same certainty
as a meta-analysis, though an evidence table with de-
scriptive themes is important for comparing quantitative
and qualitative evidence and will be useful for generating
recommendations from the final aggregation.
This knowledge synthesis will summarize and compare
the content and methodologies used to elicit women’s
preferences of cervical screening. A pooled synthesis will
highlight what is known about methods used to elicit
women’s preferences in cervical screening and their identi-
fied preferences across a diverse body of evidence. This in-
formation will contribute to the design of a tool to elicit
women’s preferences for cervical screening for potential
use by health professionals in developing woman-centered
cervical screening recommendations. These findings will
also suggest gaps in the knowledge of women’s cervical
screening preferences that can be addressed in future
research.
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